lenalidomide has been researched along with 2-(2,6-dioxopiperidin-3-yl)phthalimidine in 1 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (2-(2,6-dioxopiperidin-3-yl)phthalimidine) | Trials (2-(2,6-dioxopiperidin-3-yl)phthalimidine) | Recent Studies (post-2010) (2-(2,6-dioxopiperidin-3-yl)phthalimidine) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 21 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Che, J; Jones, LH; Kong, NR; Liu, H | 1 |
1 other study(ies) available for lenalidomide and 2-(2,6-dioxopiperidin-3-yl)phthalimidine
| Article | Year |
|---|---|
Physicochemistry of Cereblon Modulating Drugs Determines Pharmacokinetics and Disposition.
Topics: | 2021 |